Open Ac ce s s Correspondence : Osteonecrosis in childhood acute lymphoblastic leukemia : a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology ( AIEOP )
暂无分享,去创建一个
M. Valsecchi | F. Locatelli | D. Silvestri | N. Santoro | A. Testi | M. Putti | L. Notarangelo | V. Conter | E. Barisone | R. Parasole | L. L. Nigro | C. Micalizzi | A. Colombini | C. Rizzari | C. Consarino | Tommaso Mina | O. Ziino | R. Mura | F. Petruzziello | T. Casini | G. Giagnuolo | T. Mina
[1] A. Borkhardt,et al. Osteonecrosis in children with acute lymphoblastic leukemia , 2016, Haematologica.
[2] M. Loh,et al. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Harbott,et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. , 2016, Blood.
[4] D. Little,et al. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL) , 2016, Cancer medicine.
[5] M. Loh,et al. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. , 2015, Blood.
[6] J. Downing,et al. Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Relling,et al. Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. , 2014, European journal of cancer.
[8] D. Little,et al. Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis , 2013, Pediatric blood & cancer.
[9] P. Auquier,et al. Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood , 2013, Haematologica.
[10] J. Nachman. Osteonecrosis in childhood ALL. , 2011, Blood.
[11] M. Relling,et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. , 2010, Blood.
[12] M. Schrappe,et al. Osteonecrosis: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL‐BFM 95 , 2005, Pediatric blood & cancer.
[13] R. Sposto,et al. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. , 2001, Medical and pediatric oncology.
[14] H. Sather,et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] M. F. Parry,et al. A Retrospective Analysis , 1990 .